ACCR.US Access-Power & Co. Inc
- Market cap
- USD 542K
- P/E
- -
- P/B
- -
- ROE
- -21.8%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is ACCR.US undervalued?
Graham numberThe Graham number of Access-Power & Co. Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Access-Power & Co. Inc fundamental analysis
No fundamental analysis for Access-Power & Co. Inc yet.
Access-Power & Co. Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Access-Power & Co. Inc
Access-Power & Co., Inc., a medical marijuana clone company, manufactures and distributes medical marijuana clone products. It offers marijuana clone products under the Clones By Drones and Clones by Cars names; and calming pet products through mycbdpets.com. The company was founded in 1996 and is based in Grand Haven, Michigan.
Full company profileAccess-Power & Co. Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Access-Power & Co. Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2001 | 2006 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 341K | 0.00 | 29.1K | 29.8K | 34.6K | - | - | 309K | 2.06M | 2.29M | 2.10M |
| Gross Profit | 341K | 0.00 | 500.00 | 29.8K | 34.6K | - | - | 224K | 1.08M | 1.37M | 1.26M |
| Operating Income | -4.88M | -48.1K | 500.00 | 1.64K | 3.86K | -14.0K | - | 8.82K | 14.6K | 16.7K | 125K |
| EBITDA | -5.14M | - | 500.00 | 1.64K | 3.86K | 260K | - | 8.82K | 14.6K | 16.7K | 125K |
| Net Income | -4.99M | 1.06M | 500.00 | -1.00 | 3.86K | 17.9K | - | -97.7K | -327K | -297K | -184K |
| EPS | -0.06 | - | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Balance Sheet | |||||||||||
| Total Assets | 436K | 3.49K | 500.00 | 3.14K | 44.7K | - | - | 5.74M | 5.80M | 6.16M | 6.45M |
| Total Liabilities | 3.23M | 1.01M | -244K | 2.39K | 2.39K | - | - | 6.03M | 4.65M | 5.24M | 5.37M |
| Shareholders' Equity | -2.79M | -1.00M | 245K | 754.00 | 42.3K | - | - | -289K | 1.15M | 916K | 846K |
| Cash & Short-term Investments | 2.79K | 0.00 | 500.00 | 1.14 | 32.7K | - | - | 54.8K | 73.4K | 53.3K | 67.3K |
| Total Debt | 323K | - | - | - | 5.95K | - | - | 5.83M | 4.15M | 4.50M | 4.47M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -1.53M | 0.00 | 0.00 | 875.14 | -874.00 | -32.0K | - | 54.8K | -66.0K | -256K | 148K |
| Capital Expenditure | 9.52K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 1.00 | 0.00 | 0.00 | 2.66K |
| Free Cash Flow | -1.54M | - | - | 875.14 | -874.00 | -32.0K | - | 54.8K | -66.0K | -256K | 146K |
| Ratios | |||||||||||
| ROE | - | - | 0.2% | -0.1% | 9.1% | - | - | - | -28.4% | -32.4% | -21.8% |
| ROA | -1,142.8% | 30,452.1% | 100.0% | 0.0% | 8.6% | - | - | -1.7% | -5.6% | -4.8% | -2.9% |
| Net Profit Margin | -1,460.9% | - | 1.7% | 0.0% | 11.2% | - | - | -31.6% | -15.9% | -13.0% | -8.8% |
| Debt to Equity | - | - | - | - | 0.14x | - | - | - | 3.60x | 4.91x | 5.29x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Access-Power & Co. Inc dividends
Access-Power & Co. Inc has not paid dividends in the last 9 fiscal years.
Who owns Access-Power & Co. Inc
Ownership data of Access-Power & Co. Inc is not available yet.
Access-Power & Co. Inc company profile
- Company name
- Access-Power & Co. Inc
- Ticker
- ACCR.US
- Exchange
- USA Stocks
- Listed since
- Dec 22, 1997
- Sector
- Communication Services
- Industry
- Software
- Employees
- 1
- Fiscal year end
- December
- Address
- PO BOX 598, Grand Haven, MI, United States, 49417
- Phone
- 616 312 5390
- Website
- myaccess-power.com
About Access-Power & Co. Inc
Access-Power & Co., Inc., a medical marijuana clone company, manufactures and distributes medical marijuana clone products. It offers marijuana clone products under the Clones By Drones and Clones by Cars names; and calming pet products through mycbdpets.com. The company was founded in 1996 and is based in Grand Haven, Michigan.
Access-Power & Co. Inc management
2- Mr. Patrick J. JensenPresident, CFO, Treasurer & Director
- Mr. J. Stephen MillsChief Legal Counsel